Bristol-Myers tries to salvage $74 billion deal with Celgene. Meets with investors in NYC, Boston
Bristol-Myers Squibb is meeting with shareholders in Boston and New York as its $74 billion purchase of drugmaker Celgen...
Search by tag: salvage
Bristol-Myers Squibb is meeting with shareholders in Boston and New York as its $74 billion purchase of drugmaker Celgen...